SJP-002 | Clinical Trials | Upper Respiratory Infections
These findings reinforce SJP-002C’s promise as a groundbreaking therapeutic for COVID-19 and Upper Respiratory Infections, demonstrating both safety and early efficacy. While further studies are needed to validate its statistical and clinical significance, the trial results encourage continued development and exploration of the therapeutic’s broader potential.
“The strong safety profile and early symptom improvements are promising indicators of SJP-002C’s potential to make a meaningful impact in COVID-19 care,” said Jackie Iversen RPh MS, Chief Clinical Officer and Co-Founder, Sen-Jam Pharmaceutical. “We are energized by these results and remain committed to refining the efficacy of this therapeutic to serve a broader population.”
Sen-Jam is actively reviewing additional clinical data to deepen its understanding of SJP-002C’s performance and efficacy. The company is also exploring opportunities for follow-up studies that could expand the scope of the therapeutic’s application to broader patient populations and conditions.
Sen-Jam Pharmaceutical’s leadership team is attending the prestigious JPMorgan Healthcare Conference in San Francisco this week. The company invites partners, investors, and stakeholders to connect, learn more about its innovative pipeline, and explore partnership opportunities. Together, we can shape the future of healthcare. To learn more about Sen-Jam Pharmaceutical’s vision and mission, visit wefunder.com/senjam.
Sen-Jam Pharmaceutical: Revolutionizing Inflammatory and Metabolic Care
Sen-Jam Pharmaceutical (“Sen-Jam”) is pioneering a revolutionary approach to addressing chronic inflammation and metabolic disorders with its proprietary “Pleiotropic Anti-Inflammatory Remedies” (PAIR) technology. By working in harmony with the body’s innate immune system, Sen-Jam’s precision remedies target inflammation at its source, mitigating systemic risks associated with chronic conditions without suppressing immune responses.
As a leader in innovative healthcare, Sen-Jam is delivering treatments that enhance metabolic health, promote vitality, and extend health spans. The company is redefining how the world heals by focusing on solutions that balance cutting-edge science with the body’s natural resilience.
Sen-Jam Pharmaceutical Announces Planned AI Initiative for Molecule Repurposing All Posts The Sen-Jam Perspective Investor Corner Press & Media Coverage...
The End of Sickcare: From the Inside Out: A Spotlight on Cellular Longevity at the Global Passion Project Summit All...
Sen-Jam Pharmaceutical Answers Surgeon General’s Alarm with a New Therapeutic Aimed at Tackling Alcohol Related Risks All Posts The Sen-Jam...